Chronic obstructive pulmonary disease 30-day readmission metric: Risk adjustment for multimorbidity and frailty.
10.47102/annals-acadmedsg.202524
- Author:
Anthony YII
1
;
Isaac FONG
1
;
Sean Chee Hong LOH
1
;
Jansen Meng-Kwang KOH
1
;
Augustine TEE
1
Author Information
1. Department of Respiratory and Critical Care Medicine, Changi General Hospital, Singapore.
- Publication Type:Journal Article
- Keywords:
30-day readmission;
COPD;
frailty;
healthcare quality;
pulmonary;
respiratory medicine;
risk adjustment
- MeSH:
Humans;
Pulmonary Disease, Chronic Obstructive/therapy*;
Patient Readmission/trends*;
Male;
Female;
Retrospective Studies;
Aged;
Singapore/epidemiology*;
Multimorbidity;
Frailty/epidemiology*;
Middle Aged;
Risk Adjustment;
Aged, 80 and over;
Logistic Models;
Risk Factors
- From:Annals of the Academy of Medicine, Singapore
2025;54(7):419-427
- CountrySingapore
- Language:English
-
Abstract:
INTRODUCTION:The 30-day readmission rate for chronic obstructive pulmonary disease (COPD) is a common performance metric but may be confounded by factors unrelated to quality of care. Our aim was to assess how sociodemographic factors, multimorbidity and frailty impact 30-day readmission risk after COPD hospitalisation, and whether risk adjustment alters interpretation of temporal trends.
METHOD:This is a retrospective analysis of administra-tive data from October 2017 to June 2023 from Changi General Hospital, Singapore. Multivariable mixed-effects logistic regression models were used to estimate unadjusted and risk-adjusted 30-day readmission odds. Covariates included age, sex, race, Charlson Comorbidity Index (CCI), Hospital Frailty Risk Score (HFRS) and year. Temporal trends in readmission risk were compared across unadjusted and adjusted models.
RESULTS:Of the 2774 admissions, 749 (27%) resulted in 30-day readmissions. Higher CCI (CCI≥4 versus [vs] CCI=1: adjusted odds ratio [aOR] 2.00, 95% confidence interval [CI] 1.33-2.99, P=0.003; CCI 2-3 vs CCI=1: aOR 1.50, 95% CI 1.15-1.96, P=0.001) and higher HFRS (≥5 vs <5: aOR 1.29, 95% CI 1.01-1.65, P=0.04) were independently associated with increased readmission risk. While unadjusted analyses showed no significant temporal trends, the risk-adjusted model revealed a 32-35% reduction in readmission odds in 2021-2023 compared to baseline.
CONCLUSION:Multimorbidity and frailty significantly impact COPD readmissions. Risk adjustment revealed improvements in readmission risk not evident in unadjusted analyses, emphasising the importance of applying risk adjustments to ensure valid performance metrics.
